Abstract
Human N-acetyltransferase 2 (NAT2) is subject to genetic polymorphism in human populations. In addition to the reference NAT2*4 allele, two genetic variant alleles (NAT2*5B and NAT2*7B) are common in Europe and Asia, respectively. NAT2*5B possesses a signature rs1801280 T341C (I114T) single-nucleotide polymorphism (SNP), whereas NAT2*7B possesses a signature rs1799931 G857A (G286E) SNP. NAT2 alleles possessing the T341C (I114T) or G857A (G286E) SNP were recombinant expressed in yeast and tested for capacity to catalyze the O-acetylation of the N-hydroxy metabolites of heterocyclic amines (HCAs). The T341C (I114T) SNP reduced the O-acetylation of N-hydroxy-2-amino-3-methylimidazo [4,5-f] quinoline (N-OH-IQ), N-hydroxy-2-amino-3,8-dimethylimidazo [4,5-f] quinoxaline (N-OH-MeIQx) and N-hydroxy- 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (N-OH-PhIP), whereas the G857A (G286E) SNP reduced the O-acetylation of N-OH-IQ and N-OH-MeIQx but not N-OH-PhIP. The G857A (G286E) SNP significantly (p < 0.05) reduced apparent Km toward N-OH-PhIP but did not significantly (p > 0.05) affect apparent Vmax. Cultures of DNA repair-deficient Chinese hamster ovary (CHO) cells transfected with human CYP1A2 and NAT2*4, NAT2*5B or NAT2*7B alleles were incubated with various concentrations of IQ, MeIQx or PhIP and double-stranded DNA damage and reactive oxygen species (ROS) were measured. Transfection with human CYP1A2 did not significantly (p > 0.05) increase HCA-induced DNA damage and ROS over un-transfected cells. Additional transfection with NAT2*4, NAT2*5B or NAT2*7B allele increased both DNA damage and ROS. The magnitude of the increases was both NAT2 allele- and substrate-dependent showing the same pattern as observed for the O-acetylation of the N-hydroxylated HCAs suggesting that both are mediated via NAT2-catalyzed O-acetylation. The results document the role of NAT2 and its genetic polymorphism on the O-acetylation and genotoxicity of HCAs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The data for this study are available from the corresponding author upon request.
References
Bendaly J, Doll MA, Millner LM et al (2009) Differences between human slow N-acetyltransferase 2 alleles in levels of 4-aminobiphenyl-induced DNA adducts and mutations. Mutat Res 671(1–2):13–19. https://doi.org/10.1016/j.mrfmmm.2009.08.003
Cascorbi I, Drakoulis N, Brockmoller J, Maurer A, Sperling K, Roots I (1995) Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am J Hum Genet 57(3):581–592
Deitz AC, Zheng W, Leff MA et al (2000) N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev 9(9):905–910
Deitz AC, Rothman N, Rebbeck TR et al (2004) Impact of misclassification in genotype-exposure interaction studies: example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer. Cancer Epidemiol Biomarkers Prev 13(9):1543–1546
Doll MA, Hein DW (2001) Comprehensive human NAT2 genotype method using single nucleotide polymorphism-specific polymerase chain reaction primers and fluorogenic probes. Anal Biochem 288(1):106–108
Doll MA, Zang Y, Moeller T, Hein DW (2010) Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes. J Pharmacol Exp Ther 334(2):540–544. https://doi.org/10.1124/jpet.110.168567
El Kawak M, Dhaini HR, Jabbour ME, Moussa MA, El Asmar K, Aoun M (2020) Slow N-acetylation as a possible contributor to bladder carcinogenesis. Mol Carcinog 59(9):1017–1027. https://doi.org/10.1002/mc.23232
Fretland AJ, Leff MA, Doll MA, Hein DW (2001) Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms. Pharmacogenetics 11(3):207–215
Gutiérrez-Virgen JE, Piña-Pozas M, Hernández-Tobías EA et al (2023) NAT2 global landscape: genetic diversity and acetylation statuses from a systematic review. PLoS ONE 18(4):e0283726. https://doi.org/10.1371/journal.pone.0283726
Habil MR, Salazar-González RA, Doll MA, Hein DW (2022) Differences in β-naphthylamine metabolism and toxicity in Chinese hamster ovary cell lines transfected with human CYP1A2 and NAT2*4, NAT2*5B or NAT2*7B N-acetyltransferase 2 haplotypes. Arch Toxicol 96(11):2999–3012. https://doi.org/10.1007/s00204-022-03367-2
Habil MR, Salazar-González RA, Doll MA, Hein DW (2023) Effect of N-acetyltransferase 2 genetic polymorphism on 4,4’-methylenebis(2-chloroaniline)-induced genotoxicity and oxidative stress. Arch Toxicol 97(6):1773–1781. https://doi.org/10.1007/s00204-023-03508-1
Hein DW (2009) N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine. Expert Opin Drug Metab Toxicol 5(4):353–366. https://doi.org/10.1517/17425250902877698
Hein DW, Doll MA (2012) Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes. Pharmacogenomics 13(1):31–41. https://doi.org/10.2217/pgs.11.122
Hein DW, Millner LM (2021) Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review. Expert Opin Drug Metab Toxicol 17(1):9–21. https://doi.org/10.1080/17425255.2021.1840551
Hein DW, Doll MA, Rustan TD et al (1993) Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis 14(8):1633–1638
Hein DW, Rustan TD, Ferguson RJ, Doll MA, Gray K (1994) Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Arch Toxicol 68(2):129–133
Hein DW, Doll MA, Fretland AJ et al (2000) Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 9(1):29–42
Hein DW, Fretland AJ, Doll MA (2006) Effects of single nucleotide polymorphisms in human N-acetyltransferase 2 on metabolic activation (O-acetylation) of heterocyclic amine carcinogens. Int J Cancer 119(5):1208–1211
Hein DW, Doll MA, Habil MR (2022) Human N-acetyltransferase 1 and 2 differ in affinity towards acetyl-coenzyme a cofactor and N-hydroxy-arylamine carcinogens. Front Pharmacol 13:821133. https://doi.org/10.3389/fphar.2022.821133
Hickman D, Palamanda JR, Unadkat JD, Sim E (1995) Enzyme kinetic properties of human recombinant arylamine N-acetyltransferase 2 allotypic variants expressed in Escherichia coli. Biochem Pharmacol 50(5):697–703
Kamel AM, Ebid GT, Moussa HS (2015) N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia. Tumour Biol 36(8):6341–6348. https://doi.org/10.1007/s13277-015-3320-7
Kidd LR, Martin RC, Moore JH, Hein DW (2006) Genetic polymorphism of N-acetyltransferase genes as risk modifiers of colorectal cancer from consumption of well-done meat. In: Choi S, Frisco S (eds) Nutrient-gene interactions in cancer. CRC Press/Taylor & Francis Group, Boca Raton, Florida, pp 189–212
Koutros S, Kiemeney LA, Pal Choudhury P et al (2023) Genome-wide association study of bladder cancer reveals new biological and translational insights. Eur Urol 84(1):127–137. https://doi.org/10.1016/j.eururo.2023.04.020
Le Marchand L, Hankin JH, Wilkens LR et al (2001) Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 10(12):1259–1266
Le Marchand L, Hankin JH, Pierce LM et al (2002) Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii. Mutat Res 506–507:205–214
Liu HE, Hsiao PY, Lee CC, Lee JA, Chen HY (2008) NAT2*7 allele is a potential risk factor for adult brain tumors in Taiwanese population. Cancer Epidemiol Biomarkers Prev 17(3):661–665. https://doi.org/10.1158/1055-9965.EPI-07-2647
Lumbreras B, Garte S, Overvad K et al (2008) Meat intake and bladder cancer in a prospective study: a role for heterocyclic aromatic amines? Cancer Causes Control 19(6):649–656. https://doi.org/10.1007/s10552-008-9121-1
McDonagh EM, Boukouvala S, Aklillu E, Hein DW, Altman RB, Klein TE (2014) PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2. Pharmacogenet Genomics 24(8):409–425. https://doi.org/10.1097/fpc.0000000000000062
Metry KJ, Zhao S, Neale JR et al (2007) 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine-induced DNA adducts and genotoxicity in chinese hamster ovary (CHO) cells expressing human CYP1A2 and rapid or slow acetylator N-acetyltransferase 2. Mol Carcinog 46(7):553–563. https://doi.org/10.1002/mc.20302
Ruiz JD, Martinez C, Anderson K et al (2012) The differential effect of NAT2 variant alleles permits refinement in phenotype inference and identifies a very slow acetylation genotype. PLoS ONE 7(9):e44629
Salazar-González RA, Doll MA, Hein DW (2023) N-acetyltransferase 2 genetic polymorphism modifies genotoxic and oxidative damage from new psychoactive substances. Arch Toxicol 97(1):189–199. https://doi.org/10.1007/s00204-022-03383-2
Selinski S, Blaszkewicz M, Ickstadt K, Hengstler JG, Golka K (2013) Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk. Arch Toxicol 87(12):2129–2139
Sugimura T, Wakabayashi K, Nakagama H, Nagao M (2004) Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci 95(4):290–299
Syeda T, Cannon JR (2022) Potential role of heterocyclic aromatic amines in neurodegeneration. Chem Res Toxicol 35(1):59–72. https://doi.org/10.1021/acs.chemrestox.1c00274
Walia HK, Singh N, Sharma S (2022) Association of NAT-2 gene polymorphisms toward lung cancer susceptibility and prognosis in North Indian patients treated with platinum-based chemotherapy. Pharmacogenomics 23(2):97–118. https://doi.org/10.2217/pgs-2021-0080
Walls KM, Hong KU, Hein DW (2023a) Heterocyclic amines reduce insulin-induced AKT phosphorylation and induce gluconeogenic gene expression in human hepatocytes. Arch Toxicol 97(6):1613–1626. https://doi.org/10.1007/s00204-023-03488-2
Walls KM, Hong KU, Hein DW (2023b) Induction of glucose production by heterocyclic amines is dependent on N-acetyltransferase 2 genetic polymorphism in cryopreserved human hepatocytes. Toxicol Lett 383:192–195. https://doi.org/10.1016/j.toxlet.2023.07.002
Wang H, Iwasaki M, Haiman CA et al (2015) Interaction between red meat intake and NAT2 genotype in increasing the risk of colorectal cancer in Japanese and African Americans. PLoS ONE 10(12):e0144955. https://doi.org/10.1371/journal.pone.0144955
Wu H, Dombrovsky L, Tempel W et al (2007) Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases. J Biol Chem 282(41):30189–30197
Zang Y, Zhao S, Doll MA, States JC, Hein DW (2004) The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradation. Pharmacogenetics 14(11):717–723
Zang Y, Doll MA, Zhao S, States JC, Hein DW (2007) Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2. Carcinogenesis 28(8):1665–1671. https://doi.org/10.1093/carcin/bgm085
Zelber-Sagi S, Ivancovsky-Wajcman D, Fliss Isakov N et al (2018) High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance. J Hepatol 68(6):1239–1246. https://doi.org/10.1016/j.jhep.2018.01.015
Zheng W, Lee SA (2009) Well-done meat intake, heterocyclic amine exposure, and cancer risk. Nutr Cancer 61(4):437–446. https://doi.org/10.1080/01635580802710741
Funding
U.S. Public Health Service, P20-GM113226, P30-ES030283, P42-ES023716.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hein, D.W., Salazar-González, R.A., Doll, M.A. et al. The effect of the rs1799931 G857A (G286E) polymorphism on N-acetyltransferase 2-mediated carcinogen metabolism and genotoxicity differs with heterocyclic amine exposure. Arch Toxicol 97, 2697–2705 (2023). https://doi.org/10.1007/s00204-023-03577-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-023-03577-2